THOUSAND OAKS, Calif.,
Jan. 31, 2025 /PRNewswire/ -- Amgen
(NASDAQ:AMGN) today announced that it will report its fourth
quarter and full year 2024 financial results on Tuesday, February 4, 2025, after the close of the
U.S. financial markets. The announcement will be followed by a
conference call with the investment community at 4:30 p.m. ET. Participating in the call from
Amgen will be Robert A. Bradway,
chairman and chief executive officer, and other members of Amgen's
senior management team.
Live audio of the conference call will be simultaneously
broadcast over the internet and will be available to members of the
news media, investors and the general public.
The webcast, as with other selected presentations regarding
developments in Amgen's business given by management at certain
investor and medical conferences, can be found on Amgen's website,
www.amgen.com, under Investors. Information regarding presentation
times, webcast availability and webcast links are noted on Amgen's
Investor Relations Events Calendar. The webcast will be archived
and available for replay for at least 90 days after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative
medicines to help millions of patients in their fight against some
of the world's toughest diseases. More than 40 years ago, Amgen
helped to establish the biotechnology industry and remains on the
cutting-edge of innovation, using technology and human genetic data
to push beyond what's known today. Amgen is advancing a broad and
deep pipeline that builds on its existing portfolio of medicines to
treat cancer, heart disease, osteoporosis, inflammatory diseases
and rare diseases.
In 2024, Amgen was named one of the
"World's Most Innovative Companies" by Fast Company and one of
"America's Best Large Employers" by Forbes, among other external
recognitions. Amgen is one of the 30 companies that comprise the
Dow Jones Industrial Average®, and it is also part of the
Nasdaq-100 Index®, which includes the largest and most innovative
non-financial companies listed on the Nasdaq Stock Market based on
market capitalization.
For more information, visit
Amgen.com and follow Amgen
on X,
LinkedIn,
Instagram,
YouTube and
Threads.
CONTACT: Amgen, Thousand
Oaks
Elissa Snook, 609-251-1407
(media)
Justin Claeys, 805-313-9775
(investors)
View original content to download
multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2024-fourth-quarter-and-full-year-financial-results-302365715.html
SOURCE Amgen
